THOMAS MERRILL: Open Payments
NPI 1760474605 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$293 in 16 payments from 11 companies in 2025. Trend: 2023 $148 · 2024 $179 · 2025 $293
Food & beverage: $293
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $75 |
| Almatica Pharma LLC | 2 | $46 |
| SANOFI PASTEUR INC. | 2 | $36 |
| Boston Scientific Corporation | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
| Amgen Inc. | 1 | $15 |
| Novo Nordisk Inc | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: PREVNAR 20, TERIPARATIDE, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, WATCHMAN Access System, GEMTESA, ELIQUIS, UNITHROID, OTEZLA.
Industry payments across OK — which companies pay providers there.
